Krishna Institute of Medical Sciences enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


28,100	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
70.5	70.5	78.0	130	129
311	311	281	265	268
3,244	3,244	2,557	1,355	678
31,585	—	—	—	—
3,174	3,174	2,479	1,225	549
₹789.62	—	—	—	—

5,803	5,803	4,976	3,449	2,616
55.9%	55.9%	51.4%	39.3%	25.9%
0.10×	—	—	—	—

7.50×	—	—	—	—
37.93×	—	—	—	—
62.89×	—	—	—	—
4,213	3,905	3,035	2,498	2,198
833	802	783	640	604
502	519	606	494	475
—	511	582	521	432
−917	−917	−427	−126	−142
—	−973	−459	−142	−147
—	1,428	1,009	647	575

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

KIMS₹702.50

Krishna Institute of Medical Sciences Ltd.

· Pharma & Health

₹ CrorePeersAPOLLOHOSP MAXHEALTH FORTIS JUBLPHARMA INDGN ONESOURCE PFIZER POLYMEDMcap ₹28,100 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	28,100.0
- Cash, Equiv & ST Investments	129.5	129.9	78.0	70.5	70.5
+ Minority Interest	268.4	264.9	281.0	311.1	311.1
+ Total Debt	678.2	1,355.3	2,556.7	3,244.0	3,244.0
Enterprise Value	—	—	—	—	31,584.6
Net Debt (memo)	548.7	1,225.5	2,478.7	3,173.5	3,173.5
EV per Share	—	—	—	—	789.62

Total Capital	2,616.1	3,448.6	4,975.5	5,802.5	5,802.5
Total Debt/Total Capital	25.92	39.30	51.39	55.91	55.91
Total Debt/EV	—	—	—	—	0.10

EV/Sales	—	—	—	—	7.50
EV/EBITDA	—	—	—	—	37.93
EV/EBIT	—	—	—	—	62.89
Reference Items — Trailing FY Values
Sales	2,197.7	2,498.1	3,035.1	3,904.6	4,212.5
EBITDA	604.0	640.4	782.9	802.0	832.8
EBIT	474.8	493.9	605.7	518.8	502.2
Operating Cash Flow	432.1	521.1	581.8	510.8	—
Free Cash Flow	-142.4	-126.3	-427.1	-917.1	-917.1
FCFF (free cash flow to the firm)	-147.0	-142.2	-458.7	-973.3	—
Capital Expenditure	574.5	647.3	1,008.9	1,427.9	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.